Breaking News Instant updates and real-time market news.

BIOS

BioScrip

$3.09

-0.085 (-2.68%)

08:35
07/10/18
07/10
08:35
07/10/18
08:35

BioScrip appoints Richard Denness as Chief Commercial Officer

BioScrip announced the appointment of Richard Denness as Senior Vice President, Chief Commercial Officer of the company, effective July 9, 2018. Most recently, he held the position of Managing Director and Global Healthcare Lead at North Highland Consulting.

BIOS BioScrip
$3.09

-0.085 (-2.68%)

01/29/18
LSCM
01/29/18
NO CHANGE
Target $4.5
LSCM
Buy
BioScrip named a best idea for 2018 at Lake Street
Lake Street analyst Brooks O'Neil names BioScrip a best idea for 2018 following the stock's 180% rise in 2017. The analyst expects management to "continue to strengthen operations and deliver solid results in 2018." The analyst thinks that despite stalling in the Senate, the Cures Fix legislation will emerge for 2019. He keeps a Buy rating on BioScrip with a $4.50 price target.
03/08/18
CHLM
03/08/18
NO CHANGE
Target $3.5
CHLM
Buy
BioScrip price target raised to $3.50 from $2.50 at Craig-Hallum
Craig-Hallum analyst Kevin Ellich raised his price target for BioScrip to $3.50 and maintains a Buy rating on the shares. The stock is down due to an internal accounting review that could delay the annual report filing, but the company's Q4 results were better than expected, highlighted by significant gross margin expansion and solid free cash flow, Ellich tells investors in a post-earnings research note. The analyst thinks the company's adjusted EBITDA guidance could prove to be conservative. He admits, though, that it may "take time for the dust to settle" regarding the internal accounting review.
03/09/18
BRRR
03/09/18
NO CHANGE
Target $3.5
BRRR
Outperform
BioScrip shares should be bought now, says Barrington
Barrington analyst Michael Petusky says BioScrip shares should be bought now following the 15.5% selloff on the company's Q4 results. BioScrip reported "strong" Q4 results, and the investment decisions weighing on the 2018 outlook make sense, Petusky tells investors in a research note. He maintains an Outperform rating on the shares with a $3.50 price target.
06/13/18
BRRR
06/13/18
NO CHANGE
Target $3.5
BRRR
Outperform
BioScrip shares on 'cusp of really working,' says Barrington
BioScrip shares "are at the cusp of really working," Barrington analyst Michael Petusky tells investors in a research note. He keeps an Outperform rating on the stock with a $3.50 price target. The analyst believes much of the company's operational progress over the past couple of years "has been masked to some extent." The remainder of 2018's financial results are likely to come with less "noise" and better reflect the true operational improvements that have been executed at BioScrip over the past two years, the analyst contends.

TODAY'S FREE FLY STORIES

INAP

Internap

$11.00

-0.8 (-6.78%)

16:28
10/18/18
10/18
16:28
10/18/18
16:28
Syndicate
Internap files to sell common stock, no amount given »

Jefferies and Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 15

    Nov

CBRL

Cracker Barrel

$155.12

-2.31 (-1.47%)

16:28
10/18/18
10/18
16:28
10/18/18
16:28
Initiation
Cracker Barrel initiated  »

Cracker Barrel initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRA

Natera

$21.40

0.09 (0.42%)

, NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
Natera, Neon Therapeutics announce clinical trial collaboration for NEO-PV-01 »

Natera (NTRA) and Neon…

NTRA

Natera

$21.40

0.09 (0.42%)

NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

MRK

Merck

$72.22

0.42 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

CBS

CBS

$56.17

0.3 (0.54%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
CBS names David Nevins as Chief Creative Officer »

David Nevins has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

, WMT

Walmart

$96.19

-0.37 (-0.38%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
Stitch Fix promotes Mike Smith to COO and President »

On October 16, the Board…

SFIX

Stitch Fix

$25.65

0.34 (1.34%)

WMT

Walmart

$96.19

-0.37 (-0.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

  • 13

    Nov

  • 15

    Nov

CBS

CBS

$56.17

0.3 (0.54%)

16:27
10/18/18
10/18
16:27
10/18/18
16:27
Hot Stocks
CBS names Christina Spade CFO »

Christina Spade has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

CMG

Chipotle

$431.72

2.09 (0.49%)

16:26
10/18/18
10/18
16:26
10/18/18
16:26
Initiation
Chipotle initiated  »

Chipotle initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTRA

Natera

$21.40

0.09 (0.42%)

, NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

16:25
10/18/18
10/18
16:25
10/18/18
16:25
Hot Stocks
Natera and Neon Therapeutics collaborate on cancer vaccine trial »

Natera (NTRA) and Neon…

NTRA

Natera

$21.40

0.09 (0.42%)

NTGN

Neon Therapeutics

$8.32

0.31 (3.87%)

MRK

Merck

$72.22

0.42 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 23

    Oct

  • 25

    Oct

  • 29

    Oct

  • 07

    Nov

  • 27

    Nov

  • 11

    Jan

  • 16

    Feb

CTXS

Citrix

$103.40

-1.73 (-1.65%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
Citrix initiated  »

Citrix initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

DOCU

DocuSign

$46.26

-1.305 (-2.74%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
DocuSign initiated  »

DocuSign initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MSFT

Microsoft

$108.54

-2.18 (-1.97%)

16:24
10/18/18
10/18
16:24
10/18/18
16:24
Initiation
Microsoft initiated  »

Microsoft initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 28

    Oct

  • 13

    Nov

  • 28

    Nov

  • 03

    Mar

CAKE

Cheesecake Factory

$50.32

-0.79 (-1.55%)

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Initiation
Cheesecake Factory initiated  »

Cheesecake Factory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 05

    Nov

  • 14

    Nov

MYL

Mylan

$32.42

-0.61 (-1.85%)

, PFE

Pfizer

$44.02

-0.55 (-1.23%)

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Hot Stocks
Mylan announces U.S. launch of generic Depo-Provera »

Mylan (MYL) announced the…

MYL

Mylan

$32.42

-0.61 (-1.85%)

PFE

Pfizer

$44.02

-0.55 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

  • 19

    Oct

  • 22

    Oct

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

  • 13

    Nov

PYPL

PayPal

$77.50

-2.61 (-3.26%)

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Hot Stocks
PayPal reports Venmo processed about $17B of TPV in Q3 »

PayPal said: "Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 22

    Oct

  • 13

    Nov

  • 13

    Nov

  • 26

    Nov

CLDR

Cloudera

16:23
10/18/18
10/18
16:23
10/18/18
16:23
Initiation
Cloudera initiated  »

Cloudera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

PANW

Palo Alto Networks

$202.61

-3.375 (-1.64%)

16:22
10/18/18
10/18
16:22
10/18/18
16:22
Initiation
Palo Alto Networks initiated  »

Palo Alto Networks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

VRNS

Varonis

$64.72

-0.935 (-1.42%)

16:22
10/18/18
10/18
16:22
10/18/18
16:22
Initiation
Varonis initiated  »

Varonis initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 01

    Nov

  • 13

    Nov

CHKP

Check Point

$110.75

-1.34 (-1.20%)

16:22
10/18/18
10/18
16:22
10/18/18
16:22
Initiation
Check Point initiated  »

Check Point initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 10

    Dec

JCOM

j2 Global

$73.78

-1.64 (-2.17%)

16:22
10/18/18
10/18
16:22
10/18/18
16:22
Initiation
j2 Global initiated  »

j2 Global initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

FFBC

First Financial Bancorp

$27.42

-0.76 (-2.70%)

16:21
10/18/18
10/18
16:21
10/18/18
16:21
Earnings
First Financial Bancorp reports Q3 EPS 51c with items, consensus 57c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 31

    Oct

MCD

McDonald's

$166.84

0.06 (0.04%)

16:21
10/18/18
10/18
16:21
10/18/18
16:21
Initiation
McDonald's initiated  »

McDonald's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

VRNT

Verint

$45.76

-0.91 (-1.95%)

16:21
10/18/18
10/18
16:21
10/18/18
16:21
Initiation
Verint initiated  »

Verint initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VSI

Vitamin Shoppe

$9.54

-0.55 (-5.45%)

16:21
10/18/18
10/18
16:21
10/18/18
16:21
Hot Stocks
Vitamin Shoppe names Stacey Renfro Chief Customer & Digital Experience Officer »

Vitamin Shoppe announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EAT

Brinker

$47.64

-0.72 (-1.49%)

16:21
10/18/18
10/18
16:21
10/18/18
16:21
Initiation
Brinker initiated  »

Brinker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRGB

Red Robin

$37.62

-0.77 (-2.01%)

16:20
10/18/18
10/18
16:20
10/18/18
16:20
Initiation
Red Robin initiated  »

Red Robin initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.